Inventor · disambiguated record
Romas Alvydas Kudirka
Also filed as: KUDIRKA ROMAS · KUDIRKA ROMAS ALVYDAS
21 granted patents·27 pending applications·60 citations·filing 2002–2025
93Inventor score
Top patents by PatentIndex Score
48 records- 0195US9833515B2Hydrazinyl-indole compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2016·Granted Dec 5, 2017·11 cites·12 claims
- 0295US9310374B2Hydrazinyl-indole compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2013·Granted Apr 12, 2016·16 cites·13 claims
- 0393US10604483B2Hydrazinyl-pyrrolo compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2019·Granted Mar 31, 2020·5 cites·16 claims
- 0492US10888623B2Hydrazinyl-indole compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2019·Granted Jan 12, 2021·3 cites·15 claims
- 0592US10464894B2Hydrazinyl-pyrrolo compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2016·Granted Nov 5, 2019·5 cites·14 claims
- 0692US9493413B2Hydrazinyl-pyrrolo compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2014·Granted Nov 15, 2016·8 cites·17 claims
- 0790US11654199B2Thienoazepine immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2020·Granted May 23, 2023·2 cites·26 claims
- 0890US10314919B2Hydrazinyl-indole compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2017·Granted Jun 11, 2019·3 cites·17 claims
- 0989US11180451B2Hydrazinyl-pyrrolo compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2019·Granted Nov 23, 2021·2 cites·20 claims
- 1088US11097013B2Anti-HER2 antibody-maytansine conjugates and methods of use thereofREDWOOD BIOSCIENCE INC·Filed 2018·Granted Aug 24, 2021·3 cites·29 claims
- 1180US11376334B2Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugateSCHERER TECHNOLOGIES LLC R P·Filed 2020·Granted Jul 5, 2022·1 cites·16 claims
- 1280US2023068124A1Hydrazinyl-Indole Compounds and Methods for Producing a ConjugateREDWOOD BIOSCIENCE INC·Filed 2022·Application pending·0 cites
- 1375US12215080B2Hydrazinyl-pyrrolo compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2021·Granted Feb 4, 2025·0 cites·21 claims
- 1474US11426465B2Hydrazinyl-indole compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2020·Granted Aug 30, 2022·0 cites·19 claims
- 1574US2024342303A1Sulfatase-Cleavable Linkers for Antibody-Drug ConjugatesSCHERER TECHNOLOGIES LLC R P·Filed 2024·Application pending·0 cites
- 1670US12465653B2Thienoazepine immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2023·Granted Nov 11, 2025·0 cites·30 claims
- 1769US12076411B2Anti-HER2 antibody-maytansine conjugates and methods of use thereofREDWOOD BIOSCIENCE INC·Filed 2021·Granted Sep 3, 2024·0 cites·27 claims
- 1869US10124070B2Anti-HER2 antibody-maytansine conjugates and methods of use thereofREDWOOD BIOSCIENCE INC·Filed 2015·Granted Nov 13, 2018·1 cites·26 claims
- 1967US11980668B2Sulfatase-cleavable linkers for antibody-drug conjugatesSCHERER TECHNOLOGIES LLC R P·Filed 2019·Granted May 14, 2024·0 cites·15 claims
- 2062US10758628B2Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugateSCHERER TECHNOLOGIES LLC R P·Filed 2018·Granted Sep 1, 2020·0 cites·15 claims
- 2161US2022195066A1Anti-cea immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2261US2025263392A1Aminobenzazepine compounds, immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2360US2025127914A1Antibody-conjugated 8-sulfonyl-benzazepine compounds and their usesBOLT BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2458US2024197899A12-amino-4-carboxamide-benzazepine immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2558US2025145575A1Macromolecule-supported 8-sulfonyl-benzazepine compounds and their usesBOLT BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2658US2024299569A12-amino-4-carboxamide-benzazepine immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2757US10195283B2Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugateSCHERER TECHNOLOGIES LLC R P·Filed 2017·Granted Feb 5, 2019·0 cites·17 claims
- 2856US2025000995A1Tlr agonist immunoconjugates with cysteine-mutant antibodies, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2955US2024417486A1Asymmetric bis-benzimidazole sting agonist immunoconjugates and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3055US2023263903A1Pyrazoloazepine immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3154US2025057967A2Bis-benzimidazole sting agonist immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3253US2024033370A1Anti-pd-l1 immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3353US2020390899A1Aminobenzazepine compounds, immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3453US2024238430A1Anti-cea immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3552US2024042050A1Anti-her2 immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3652US2023257393A1Macromolecule-supported thienoazepine compounds, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3752US2024091370A1Anti-her2 immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3849US2023293716A1Elastase-substrate, peptide linker immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3947US7034147B2Nucleoside analog librariesIRM LLC·Filed 2003·Granted Apr 25, 2006·0 cites·18 claims
- 4046US2022152215A1Immunoconjugates Targeting CEABOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4146US2022226492A1Immunoconjugates Targeting HER2BOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4246US2022347312A1Immunoconjugate Synthesis MethodBOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4346US2022226491A1Immunoconjugates Targeting PD-L1BOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4446US2022143012A1Macromolecule-Supported TLR AgonistsBOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4545US2004006176A1Nucleoside analog librariesIRM LLC·Filed 2002·Application pending·0 cites
- 4645US2022313835A1Aminoquinoline compounds, immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4745US2022347310A1Amide-linked, aminobenzazepine immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4839US9579390B2Compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2015·Granted Feb 28, 2017·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Romas Alvydas Kudirka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →